Kasai K, Hirabayashi J. Galectins: a family of animal lectins that decipher glycocodes. J Biochem 1996; 119: 1–8.
Wang JL, Gray RM, Haudek KC, Patterson RJ. Nucleocytoplasmic lectins. Biochim Biophys Acta 2004; 1673: 75–93.
Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005; 5: 29–41.
Nakahara S, Oka N, Raz A. On the role of galectin-3 in cancer apoptosis. Apoptosis 2005; 10: 267–275.
Yang RY, Yu L, Graham JL, Hsu DK, Lloyd KC, Havel PJ et al. Ablation of a galectin preferentially expressed in adipocytes increases lipolysis, reduces adiposity, and improves insulin sensitivity in mice. Proc Natl Acad Sci USA 2011; 108: 18696–18701.
Hotta K, Funahashi T, Matsukawa Y, Takahashi M, Nishizawa H, Kishida K et al. Galectin-12, an adipose-expressed galectin-like molecule possessing apoptosis-inducing activity. J Biol Chem 2001; 276: 34089–34097.
Norling LV, Perretti M, Cooper D. Endogenous galectins and the control of the host inflammatory response. J Endocrinol 2009; 201: 169–184.
Chou FC, Shieh SJ, Sytwu HK. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol 2009; 39: 2403–2411.
Barondes SH, Cooper DN, Gitt MA, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994; 269: 20807–20810.
Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature 1995; 378: 736–739.
Chung CD, Patel VP, Moran M, Lewis LA, Miceli MC. Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol 2000; 165: 3722–3729.
Cooper D, Ilarregui JM, Pesoa SA, Croci DO, Perretti M, Rabinovich GA. Multiple functional targets of the immunoregulatory activity of galectin-1: control of immune cell trafficking, dendritic cell physiology, and T-cell fate. Methods Enzymol 2010; 480: 199–244.
Perone MJ, Bertera S, Shufesky WJ, Divito SJ, Montecalvo A, Mathers AR et al. Suppression of autoimmune diabetes by soluble galectin-1. J Immunol 2009; 182: 2641–2653.
Ahmed M, Neville MJ, Edelmann MJ, Kessler BM, Karpe F. Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity 2010; 18: 27–34.
Rhodes DH, Pini M, Castellanos KJ, Montero-Melendez T, Cooper D, Perretti M et al. Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function. Obesity 2013; 21: 310–319.
Wang P, Mariman E, Keijer J, Bouwman F, Noben JP, Robben J et al. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci 2004; 61: 2405–2417.
Kim DH, Choi JW, Joo JI, Wang X, Choi DK, Oh TS et al. Changes in expression of skeletal muscle proteins between obesity-prone and obesity-resistant rats induced by a high-fat diet. J Proteome Res 2011; 10: 1281–1292.
Choi JW, Liu H, Choi DK, Oh TS, Mukherjee R, Yun JW. Profiling of gender-specific rat plasma proteins associated with susceptibility or resistance to diet-induced obesity. J Proteomics 2012; 75: 1386–1400.
Liu H, Choi JW, Yun JW. Gender differences in rat plasma proteome in response to high-fat diet. Proteomics 2012; 12: 269–283.
Mukherjee R, Kim SW, Choi MS, Yun JW. Sex-dependent expression of caveolin 1 in response to sex steroid hormones is closely associated with development of obesity in rats. PLoS ONE 2014; 9: e90918.
Astorgues-Xerri L, Riveiro ME, Tijeras-Raballand A, Serova M, Neuzillet C, Albert S et al. Unraveling galectin-1 as a novel therapeutic target for cancer. Cancer Treat Rev 2014; 40: 307–319.
Stannard KA, Collins PM, Ito K, Sullivan EM, Scott SA, Gabutero E et al. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer Lett 2010; 299: 95–110.
Ito K, Scott SA, Cutler S, Dong LF, Neuzil J, Blanchard H et al. Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. Angiogenesis 2011; 14: 293–307.
Ito K, Ralph SJ. Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence. Clin Exp Metastasis 2012; 29: 561–572.
Szebeni GJ, Kriston-Pal E, Blazso P, Katona RL, Novak J, Szabo E et al. Identification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotion. PLoS ONE 2012; 7: e41372.
Delaine T, Cumpstey I, Ingrassia L, Le Mercier M, Okechukwu P, Leffler H et al. Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells. J Med Chem 2008; 51: 8109–8114.
Mukherjee R, Yun JW. Bromocriptine inhibits adipogenesis and lipogenesis by agonistic action on alpha2-adrenergic receptor in 3T3-L1 adipocyte cells. Mol Biol Rep 2013; 40: 3783–3792.
Karamanlidis G, Karamitri A, Docherty K, Hazlerigg DG, Lomax MA. C/EBPbeta reprograms white 3T3-L1 preadipocytes to a Brown adipocyte pattern of gene expression. J Biol Chem 2007; 282: 24660–24669.
Hausman DB, Park HJ, Hausman GJ. Isolation and culture of preadipocytes from rodent white adipose tissue. Methods Mol Biol 2008; 456: 201–219.
Bridges D, Chang L, Lodhi IJ, Clark NA, Saltiel AR. TC10 is regulated by caveolin in 3T3-L1 adipocytes. PLoS One 2012; 7: e42451.
Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010; 38: W214–W220.
Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J et al. STRING 8—a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009; 37: D412–D416.
Pejnovic NN, Pantic JM, Jovanovic IP, Radosavljevic GD, Milovanovic MZ, Nikolic IG et al. Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 2013; 62: 1932–1944.
Pang J, Rhodes DH, Pini M, Akasheh RT, Castellanos KJ, Cabay RJ et al. Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice. PLoS One 2013; 8: e57915.
Weigert J, Neumeier M, Wanninger J, Bauer S, Farkas S, Scherer MN et al. Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J Clin Endocrinol Metab 2010; 95: 1404–1411.
Kiwaki K, Novak CM, Hsu DK, Liu FT, Levine JA. Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue. Obesity 2007; 15: 32–39.
Yang RY, Hsu DK, Yu L, Chen HY, Liu FT. Galectin-12 is required for adipogenic signaling and adipocyte differentiation. J Biol Chem 2004; 279: 29761–29766.
Goldring K, Jones GE, Thiagarajah R, Watt DJ. The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro. J Cell Sci 2002; 115: 355–366.
Patterson RJ, Wang W, Wang JL. Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus. Glycoconj J 2004; 19: 499–506.
Masamune A, Satoh M, Hirabayashi J, Kasai K, Satoh K, Shimosegawa T. Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2006; 290: G729–G736.
Vyakarnam A, Dagher SF, Wang JL, Patterson RJ. Evidence for a role for galectin-1 in pre-mRNA splicing. Mol Cell Biol 1997; 17: 4730–4737.
Clemens MJ, Henshaw EC, Rahamimoff H, London IM. Met-tRNAfMet binding to 40S ribosomal subunits: a site for the regulation of initiation of protein synthesis by hemin. Proc Natl Acad Sci USA 1974; 71: 2946–2950.
Gao H, Meng J, Xu M, Zhang S, Ghose B, Liu J et al. Serum heat shock protein 70 concentration in relation to polycystic ovary syndrome in a non-obese chinese population. PLoS One 2013; 8: e67727.
Ye R, Jung DY, Jun JY, Li J, Luo S, Ko HJ et al. Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. Diabetes 2010; 59: 6–16.
Salgado-Somoza A, Teijeira-Fernandez E, Fernandez AL, Gonzalez-Juanatey JR, Eiras S. Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease. Atherosclerosis 2012; 224: 492–499.
Leggate M, Carter WG, Evans MJ, Vennard RA, Sribala-Sundaram S, Nimmo MA. Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males. J Appl Physiol (1985) 2012; 112: 1353–1360.
Pal P, Kanaujiya JK, Lochab S, Tripathi SB, Sanyal S, Behre G et al. Proteomic analysis of rosiglitazone and guggulsterone treated 3T3-L1 preadipocytes. Mol Cell Biochem 2013; 376: 81–93.
Ding Y, Wu Y, Zeng R, Liao K. Proteomic profiling of lipid droplet-associated proteins in primary adipocytes of normal and obese mouse. Acta Biochim Biophys Sin (Shanghai) 2012; 44: 394–406.
Heid H, Rickelt S, Zimbelmann R, Winter S, Schumacher H, Dorflinger Y et al. On the formation of lipid droplets in human adipocytes: the organization of the perilipin-vimentin cortex. PLoS One 2014; 9: e90386.
Caviglia JM, Betters JL, Dapito DH, Lord CC, Sullivan S, Chua S et al. Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity. J Lipid Res 2011; 52: 2032–2042.
Zu L, He J, Jiang H, Xu C, Pu S, Xu G. Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway. J Biol Chem 2009; 284: 5915–5926.
Jimenez-Gomez Y, Cruz-Teno C, Rangel-Zuniga OA, Peinado JR, Perez-Martinez P, Delgado-Lista J et al. Effect of dietary fat modification on subcutaneous white adipose tissue insulin sensitivity in patients with metabolic syndrome. Mol Nutr Food Res 2014; 58: 2177–2188.
Lieber JG, Evans RM. Disruption of the vimentin intermediate filament system during adipose conversion of 3T3-L1 cells inhibits lipid droplet accumulation. J Cell Sci 1996; 109: 3047–3058.
Astorgues-Xerri L, Riveiro ME, Tijeras-Raballand A, Serova M, Rabinovich GA, Bieche I et al. OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis. Eur J Cancer 2014; 50: 2463–2477.
Voss PG, Haudek KC, Patterson RJ, Wang JL. Inhibition of cell-free splicing by saccharides that bind galectins and SR proteins. J Carbohydr Chem 2012; 31: 519–534.